Log In
Print
BCIQ
Print
Print this Print this
 

Cenicriviroc (formerly TBR-652)

Also known as: formerly TAK-652

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionDual CC chemokine receptor 5 (CCR5) and CCR2 antagonist
Molecular Target CC chemokine receptor 5 (CCR5) (CD195) ; CC chemokine receptor 2 (CCR2) (CD192)
Mechanism of ActionCC chemokine receptor 2 (CCR2) antagonist; CC chemokine receptor 5 (CCR5) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation

Partner

Tobira Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today